Contact
🔒 Contacts are masked. Get full emails & phones. Unlock via export ↗
Category & trade
Primary
pharmaceutical-drugs · embed-ft 0.22
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Tech stack
AI readiness
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
llms.txt ai.txt humans.txt robots.txt
Compliance (GEO / GDPR)
TLD
Overview
Title
DUPIXENT® (dupilumab) for Allergic Fungal Rhinosinusitis (AFRS)
Description
Learn more about DUPIXENT® (dupilumab), the only FDA-approved biologic treatment for adults & children 6 years of age and older with allergic fungal rhinosinusitis (AFRS) who have had surgery on their nose or sinuses in the past. Serious side effects can occur. Please see Important Safety Information and Prescribing Information and Patient Information on website.
Final URL
Language
en (html)
Scanned at
2026-06-29 07:06:39